POAI Stock Price Plummeted By 2.63%. Here is what happened
Predictive Oncology (NASDAQ: POAI), an oncology and drug discovery company with an emphasis on artificial intelligence, confirmed that its wholly-owned daughter company, TumorGenesis has established a deal with the Swedish firm Cellevate AB. The companies have planned to combineTumorGenesis’ medias with Cellevate’s high engineered matrix materials. The complementary nature of their businesses is anticipated to […]
